Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, May 6 2016 8:59pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Friday, May 6, 2016
·Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming May 9 Deadline in the Securities Class Action Against Horizon Pharma plc and Encourages Investors to Contact the Firm
Business Wire - 59 minutes ago
·SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Horizon Pharma plc To Contact The Firm Before Lead Plaintiff Deadline
- 1 hour, 18 minutes ago
·UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders of Horizon Pharma plc of Class Action Lawsuit and a Lead Plaintiff Deadline of May 9, 2016 - HZNP
PR Newswire - 2 hours, 29 minutes ago
·Neurocrine Biosciences Announces Additional Valbenazine (NBI-98854) Data to be Presented at the American Psychiatric Association's 2016 Annual Meeting in Atlanta
PR Newswire - Fri 8:30 am ET
·Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Wednesday, May 11th, 2016
GlobeNewswire - Fri 8:03 am ET
·Endo reports 1st-quarter loss, trims full-year guidance
AP - Thu 6:54 pm ET
·Neurocrine reports 1Q loss
AP - Thu 6:22 pm ET
Thursday, May 5, 2016
·Teva Pharm finalizing asset sales to clear Allergan deal -source
Reuters - Thu 4:12 pm ET
·Neurocrine Biosciences Reports First Quarter 2016 Results
PR Newswire - Thu 4:01 pm ET
·pSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results
GlobeNewswire - Thu 4:01 pm ET
·Sophiris Bio To Present Topsalysin Phase 3 Data from Positive PLUS-1 Study as a Late Breaking Poster During the 111th American Urological Association Annual Meeting
PR Newswire - Thu 4:00 pm ET
·Juniper Pharmaceuticals Announces Publication of Phase 1 Study Demonstrating Ability of Its Proprietary Intravaginal Ring to Deliver Large Molecules
PR Newswire - Thu 11:54 am ET
·Aquinox Pharmaceuticals Announces Presentation of LEADERSHIP 201 Results at Upcoming American Urological Association Annual Meeting
GlobeNewswire - Thu 9:15 am ET
·Flexion Therapeutics to Report First-Quarter 2016 Financial Results on May 12, 2016
GlobeNewswire - Thu 8:30 am ET
·Horizon Pharma plc Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE(R) (interferon gamma-1b) for the Treatment of People With Friedreich's Ataxia
Marketwire - Thu 8:30 am ET
·Fibrocell Science reports 1Q loss
AP - Thu 8:28 am ET
·Preclinical Research on the Role of Galectin-3 in Pulmonary Arterial Hypertension to be Presented at the American Thoracic Society 2016 International Conference
GlobeNewswire - Thu 8:00 am ET
·Fibrocell Reports First Quarter 2016 Financial Results and Operational Highlights
GlobeNewswire - Thu 8:00 am ET
·Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2016 Financial Results
GlobeNewswire - Thu 8:00 am ET
·Mylan Launches Generic Apresoline┬« Injection
PR Newswire - Thu 7:30 am ET
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?